To include your compound in the COVID-19 Resource Center, submit it here.

Sequella deal

Sequella granted Russian financial firm Maxwell Biotech Venture Fund exclusive rights to develop and commercialize tuberculosis (TB) candidate SQ109 in

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE